XML 17 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Statements of Cash Flows - USD ($)
3 Months Ended
Sep. 30, 2018
Sep. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (1,841,463) $ (2,005,555)
Adjustments to reconcile net loss to net cash used in operating activities    
Preferred shares issued as compensation 55,027 158,799
Common shares issued as compensation and for services 86,960 38,250
Warrants granted to Scientific Advisory Board 1,543 5,773
Stock-based compensation expense 11,920 0
Depreciation 171,320 166,189
Amortization 2,069 2,068
Change in fair value of derivative liability (175,551) (564,848)
Amortization of debt discount on convertible debenture 0 239,351
Changes in operating assets and liabilities:    
Prepaid expenses 38,725 (2,254)
Other assets 1,425 14,257
Accounts payable 96,758 (45,427)
Accounts payable - related party 610,989 478,088
Accrued expenses (21,874) 188
Deferred interest payable 0 (41,667)
NET CASH USED IN OPERATING ACTIVITIES (962,152) (1,556,788)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (37,254) (30,433)
NET CHANGE IN CASH AND CASH EQUIVALENTS (999,406) (1,587,221)
Cash and cash equivalents at beginning of period 7,081,771 15,099,461
Cash and cash equivalents at end of period 6,082,365 13,512,240
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:    
Interest paid $ 0 $ 166,667